Zum Inhalt springen

Our Sponsors 2025

We would like to thank our sponsors for supporting the 41st Annual Meeeting German Association for the Study of the Liver (GASL) evolve!

Your GASL Organising Team

 

Gilead Sciences GmbH 

Gilead has been present in Germany since 1991. Based in Martinsried, more than 300 people work on our company’s mission to discover, develop and commercialize innovative medicines for medical areas where there is a high demand for medical progress.

Homepage: https://www.gileadpro.de/

8.000,00€*

Institut AllergoSan Deutschland (privat) GmbH

Homepage: https://www.allergosan.com/en/

6.500,00€*

Chiesi GmbH

Chiesi is an international biopharmaceutical group based in Parma, Italy. The company values societal and individual well-being as much as economic success. As a certified B Corp, Chiesi meets high standards of social and environmental performance, accountability and transparency.

Homepage: https://www.chiesi.de/

6.500,00€*

Dr. Falk Pharma GmbH

Dr. Falk Pharma GmbH has been developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis for over 60 years. The focus is on the development and distribution of innovative medicines that improve patients’ health and well-being. As the international experts in digestive and metabolic medicine, Dr. Falk Pharma has ten affiliates in Europe and Australia and is continuously growing. The family-owned business has its headquarters and R&D facilities in Freiburg, Germany, its pharmaceutical products are manufactured in Europe, mainly at sites in Germany, France, Italy and Switzerland.

Homepage: https://de.drfalkpharma.com/de/

6.500,00€*

GSK (GlaxoSmithKline GmbH & Co. KG)

GSK is a global biopharma company with strong momentum and big ambitions to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade,as a company where people can thrive. We focus on four therapeutic areas: infectious diseases, HIV, oncology and immunology including respiratory.

From basic research, clinical development to manufacturing and commercialization of our products, GSK is closely associated with Germany as a business and science location: GSK has facilities in Munich, Heidelberg, Dresden and Marburg.

Homepage: https://www.gsk.com/en-gb/

6.500,00€*

Ipsen Pharma GmbH

We are a medium-sized globally operating biopharmaceutical company that develops innovative pharmaceutical products for people with rare or severe diseases to significantly improve their health and quality of life.

Elafibranor (Iqirvo) is a once daily ppar-Agonist approved in the EU (and US) for the primary biliary cholangitis (PBC) in combination with UDCA in adult patients an inadequately response to UDCA or as monotherapy in patients who cannot tolerate UDCA.

Odevixibat (Bylvay®/Kayfanda®) is a once-daily IBAT inhibitor approved in the EU (and US) for PFIC and ALGS-related pruritus in patients 6+ months. It has orphan exclusivity for the treatment of all PFIC types in the EU.

Homepage: https://www.ipsen.com/germany/

6.500,00€*

Madrigal Pharmaceuticals, Inc.

Madrigal is a biopharmaceutical company pursuing novel therapeutics for metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of MASH with compensated cirrhosis.

Homepage: https://www.madrigalpharma.com/

6.500,00€*

AstraZeneca GmbH

AstraZeneca GmbH is the German subsidiary of the British-Swedish pharmaceutical company AstraZeneca PLC. AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines in the areas of oncology, rare diseases and biopharmaceuticals, including cardiovascular, renal and metabolic, respiratory and immunology. Headquartered in Cambridge, UK, AstraZeneca operates in over 100 countries. The company’s innovative medicines are used by millions of patients worldwide. Further information can be found at www.astrazeneca.de.

Homepage: https://www.astrazeneca.com/

6.000,00 €*

Roche Diagnostics Deutschland GmbH

Since Roche founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.

Homepage: https://www.roche.de/diagnostik/produkte-loesungen/digitale-loesungen/gaad-algorithmus

4.000,00€*

AbbVie Deutschland GmbH & Co. KG

Homepage: https://www.abbvie.com/

3.500,00€*

Boehringer Ingelheim Pharma GmbH & Co. KG

We have been transforming lives in healthcare since 1885. Our 53,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units. We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.

Homepage: www.boehringer-ingelheim.com/

3.500,00€*

Bristol-Myers Squibb GmbH & Co. KGaA

Homepage: https://www.bms-onkologie.de/

3.500,00€*

Alfasigma GmbH

Homepage: https://www.alfasigmausa.com/

3.500,00€*

Incyte Corporation

Homepage: https://www.Incyte.com

3.500,00€*

Mirum Pharmaceuticals Germany GmbH

Homepage: https://mirumpharma.com/

3.500,00€*

Sirtex Medical Europe GmbH

Homepage: https://sirtex.com/de/

3.500,00€*

Novo Nordisk Pharma GmbH 

Homepage: https://www.novonordisk.com/

3.500,00€*

* all amounts exclude VAT